Hitting A Moving Target: Teva’s Dethlefs Discusses US Complex Generics
Lack Of Clarity Over FDA Expectations And Mid-Cycle Changes Add To Challenges
• By David Wallace
Teva’s Sven Dethlefs talks about the challenges of bringing complex generics to market • Source: Teva 
